Plasminogen depletion during streptokinase treatment or two-chain urokinase incubation correlates with decreased clot lysability ex vivo and in vitro
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
1993-12-20
Metadata
Show full item recordCitation
Thromb. Haemost. 1993, 70(6):998-1004Abstract
The relationship between lytic state variables and ex vivo clot lysability was investigated in blood drawn from patients during streptokinase administration for acute myocardial infarction. A lytic state was already evident after 5 min of treatment and after 20 min the plasminogen concentration had decreased to 24%, antiplasmin to 7% and fibrinogen 0.2 g/l. Lysis of radiolabeled retracted clots in the patient plasmas decreased from 37 +/- 8% after 5 min to 21 +/- 8% at 10 min and was significantly lower (8 +/- 9%, p < 0.005) in samples drawn at 20, 40 and 80 min. Clot lysability correlated positively with the plasminogen concentration (r = 0.78, p = 0.003), but not with plasmin activity. Suspension of radiolabeled clots in normal plasma pre-exposed to 250 U/ml two-chain urokinase for varying time to induce an in vitro lytic state was also associated with decreasing clot lysability in direct proportion with the duration of prior plasma exposure to urokinase. The decreased lysability correlated with the time-dependent reduction in plasminogen concentration (r = 0.88, p < 0.0005). Thus, clot lysability decreases in conjunction with the development of the lytic state and the associated plasminogen depletion. The lytic state may therefore limit reperfusion during thrombolytic treatment.Collections
Related articles
- Depletion of plasminogen in vitro or during thrombolytic therapy limits fibrinolytic potential.
- Authors: Onundarson PT, Francis CW, Marder VJ
- Issue date: 1992 Jul
- Fibrin clot lysis by thrombolytic agents is impaired in newborns due to a low plasminogen concentration.
- Authors: Andrew M, Brooker L, Leaker M, Paes B, Weitz J
- Issue date: 1992 Sep 7
- [Initial experiences with pro-urokinase in acute myocardial infarct].
- Authors: Schanzenbächer P, Huber J, Keller F, Kochsiek K
- Issue date: 1987 Sep
- Systemic fibrinolytic activity and inhibitor levels during treatment of deep vein thrombosis with urokinase and streptokinase.
- Authors: Theiss W, Asbeck F, Kriessmann A, Trübestein G, Knoch K, de Swart CA, Marbert GA, van de Loo JC
- Issue date: 1983 Oct 31
- In vitro simulation of therapeutic thrombolysis with microtiter plate clot-lysis assay.
- Authors: Stief TW
- Issue date: 2006 Jan